Searched for
WOCKHARDT BIO AG
Wockhardt exits US generics biz to focus on drug discoveryWockhardt is set to exit its loss-making US generics business to prioritize innovation, focusing on new antibiotic drug discovery and its b...- Wockhardt Ltd dumps US generic pharma segment after losses, bets on antibiotics and insulinWockhardt Ltd has decided to shut down its loss-making US generics business to channel its energy and funds into developing new antibiotics...
- Wockhardt, Jemincare partner for novel respiratory antibiotic NafithromycinOn the development, Wockhardt Group Founder Chairman Habil Khorakiwala said Wockhardt has been at the forefront in the fight against Anti-M...
- Wockhardt gets USFDA nod for generic anti-bacterial drugThe application for the product to the US Food and Drug Administration (USFDA) was made by the company's subsidiary Wockhardt Bio AG, the M...
- Wockhardt Q2 slides 81.6% to Rs 17 croreNet profit was Rs 92.45 crore in July-September a year ago, Wockhardt said in a BSE filing.
- Wockhardt board endorses European listing of its Swiss armDrug maker Wockhardt today said its board has endorsed the decision of its Switzerland-based arm Wockhardt Bio AG to undertake a European l...
Load More